Nutritional management of glycogen storage disease type III: a case report and a critical appraisal of the literature
Open Access
- 11 May 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 10
Abstract
Glycogen storage disease Type III (GSD III) is an autosomal recessive disease due to the deficiency of the debranching enzyme, which has two main consequences: a reduced availability of glucose due to the incomplete degradation of glycogen, and the accumulation of abnormal glycogen in liver and cardiac/skeletal muscle. The role of dietary lipid manipulations in the nutritional management of GSD III is still debated. A literature overview shows that low-carbohydrate (CHO) / high-fat diets may be beneficial in reducing muscle damage. We present a 24-year GSD IIIa patient with severe myopathy and cardiomyopathy in whom a gradual shift from a high-CHO diet (61% total energy intake), low-fat (18%), high-protein (21%) to a low-CHO (32 %) high-fat (45%) / high-protein (23%) diet was performed. CHO was mainly represented by high-fiber, low glycemic index food, and fat consisted prevalently of mono and polyunsaturated fatty acids. After a 2-year follow-up, all biomarkers of muscle and heart damage markedly decreased (by 50–75%), glucose levels remained within the normal range and lipid profile was unchanged. At echocardiography, there was an improvement in geometry and left ventricular function. A low -CHO, high-fat, high-protein diet seems to be safe, sustainable and effective in reducing muscle damage without worsening cardiometabolic profile in GSDIIIa. This dietary approach could be started as early as possible in GSD III displaying skeletal/cardiac muscle disease in order to prevent/minimize organ damage.Keywords
This publication has 27 references indexed in Scilit:
- Glycogen storage disease type III: modified Atkins diet improves myopathyOrphanet Journal of Rare Diseases, 2014
- Improvement of Cardiomyopathy After High-Fat Diet in Two Siblings with Glycogen Storage Disease Type III2014
- Heart Failure Due to Severe Hypertrophic Cardiomyopathy Reversed by Low Calorie, High Protein Dietary Adjustments in a Glycogen Storage Disease Type IIIa Patient2011
- Successful Treatment of Severe Cardiomyopathy in Glycogen Storage Disease Type III With D,L-3-Hydroxybutyrate, Ketogenic and High-Protein DietPediatric Research, 2011
- Gaucher disease type I: Assessment of basal metabolic rate in patients from southern BrazilBlood Cells, Molecules, and Diseases, 2011
- Glycogen Storage Disease Type III diagnosis and management guidelinesGenetics in Medicine, 2010
- Reversal of glycogen storage disease type IIIa‐related cardiomyopathy with modification of dietJournal of Inherited Metabolic Disease, 2009
- D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD)The Lancet, 2003
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985
- Reversal of debrancher deficiency myopathy by the use of high‐protein nutritionAnnals of Neurology, 1982